Borgess Diabetes Center — Kalamazoo, Michigan

Borgess Diabetes Center is a clinical research site located in Kalamazoo, Michigan, United States 49048.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Borgess Diabetes Center has participated in 2 clinical trials.

Therapeutic areas: Painful Diabetic Peripheral Neuropathy, Diabetic Neuropathy, Painful.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Borgess Diabetes Center?

Borgess Diabetes Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Borgess Diabetes Center conducted?

Borgess Diabetes Center has 2 clinical trials on record. Their work covers Painful Diabetic Peripheral Neuropathy, Diabetic Neuropathy, Painful.

Is Borgess Diabetes Center accredited by Crixeo Health?

Borgess Diabetes Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Borgess Diabetes Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.